70 related articles for article (PubMed ID: 15172115)
1. Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate.
Katoh M; Feldhaus S; Schnitzer T; Bauer S; Schumacher U
Cancer Lett; 2004 Jul; 210(1):7-15. PubMed ID: 15172115
[TBL] [Abstract][Full Text] [Related]
2. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
3. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and reversal of malignant changes in colon cancer through PPARgamma.
Sarraf P; Mueller E; Jones D; King FJ; DeAngelo DJ; Partridge JB; Holden SA; Chen LB; Singer S; Fletcher C; Spiegelman BM
Nat Med; 1998 Sep; 4(9):1046-52. PubMed ID: 9734398
[TBL] [Abstract][Full Text] [Related]
5. Are physiological clonal expansion and maturation pathways a basis for discrepant behaviour of colon tumoral cell growth in response to the thiazolidinedione PPARgamma agonists?
Vamecq J; Latruffe N
Oncol Rep; 1999; 6(6):1281-3. PubMed ID: 10523697
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M
Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands.
Bogazzi F; Ultimieri F; Raggi F; Russo D; Vanacore R; Guida C; Brogioni S; Cosci C; Gasperi M; Bartalena L; Martino E
Endocrinology; 2004 Jul; 145(7):3353-62. PubMed ID: 15070854
[TBL] [Abstract][Full Text] [Related]
9. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
[TBL] [Abstract][Full Text] [Related]
11. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
12. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
Cho SD; Yoon K; Chintharlapalli S; Abdelrahim M; Lei P; Hamilton S; Khan S; Ramaiah SK; Safe S
Cancer Res; 2007 Jan; 67(2):674-83. PubMed ID: 17234778
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
Hayashi N; Nakamori S; Hiraoka N; Tsujie M; Xundi X; Takano T; Amino N; Sakon M; Monden M
Int J Oncol; 2004 Jan; 24(1):89-95. PubMed ID: 14654945
[TBL] [Abstract][Full Text] [Related]
14. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
15. The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines.
Strakova N; Ehrmann J; Dzubak P; Bouchal J; Kolar Z
J Pharmacol Exp Ther; 2004 Jun; 309(3):1239-47. PubMed ID: 14988421
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
18. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease.
Hsueh WA; Bruemmer D
Hypertension; 2004 Feb; 43(2):297-305. PubMed ID: 14732733
[TBL] [Abstract][Full Text] [Related]
20. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
